Keyphrases
Major Depressive Disorder
100%
Treatment-resistant Depression
100%
Randomized Trial
100%
N-methyl-D-aspartate Receptor Antagonist
100%
Confidence Interval
66%
Placebo
66%
Ketamine
66%
Mood Disorders
66%
Rapid-acting Antidepressant
66%
Randomized Placebo-controlled Trial
33%
Pathophysiology
33%
Antidepressants
33%
DSM-IV
33%
Depression Treatment
33%
After Injection
33%
Remission Criteria
33%
National Institute of Mental Health
33%
N-methyl-D-aspartate Receptor (NMDAR)
33%
Ketamine Hydrochloride
33%
Drug-free
33%
Change of Measure
33%
Efficacy Index
33%
Hamilton Depression Rating Scale (HAM-D)
33%
Glutamatergic System
33%
Intravenous Infusion
33%
Treatment-resistant
33%
Intravenous Dose
33%
Onset of Action
33%
Rapid Onset
33%
Lines of Evidence
33%
Impact on Care
33%
Pharmacological Strategies
33%
Ketamine Infusion
33%
Free-running Period
33%
Pharmacology, Toxicology and Pharmaceutical Science
Treatment Resistant Depression
100%
Ketamine
100%
Aspartic Acid
100%
Placebo
75%
Antidepressant
75%
Mood Disorder
50%
Major Depression
50%
Pathophysiology
25%
Remission
25%
Receptor
25%
DSM-IV
25%
Neuroscience
Aspartic Acid
100%
Treatment-Resistant Depression
100%
Ketamine
100%
Antidepressant
75%
Placebo
75%
Major Depressive Disorder
50%
Mood Disorder
50%
Crossover Study
25%
Hamilton Rating Scale for Depression
25%
Receptor
25%